Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06NGR
|
||||
Former ID |
DNC003448
|
||||
Drug Name |
7-Methyl-Gpppa
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551393] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H30N10O17P3+
|
||||
Canonical SMILES |
CN1C=[N+](C2=C1C(=O)N=C(N2)N)C3C(C(C(O3)COP(=O)(O)OP(=O<br />)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C5N=CN=C6N)O)O)O)O
|
||||
InChI |
1S/C21H29N10O17P3/c1-29-6-31(17-10(29)18(36)28-21(23)27-17)20-14(35)12(33)8(46-20)3-44-50(39,40)48-51(41,42)47-49(37,38)43-2-7-11(32)13(34)19(45-7)30-5-26-9-15(22)24-4-25-16(9)30/h4-8,11-14,19-20,32-35H,2-3H2,1H3,(H7-,22,23,24,25,27,28,36,37,38,39,40,41,42)/p+1/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1
|
||||
InChIKey |
QQOHNVHGNZYSBP-XPWFQUROSA-O
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Eukaryotic translation initiation factor 4E | Target Info | Inhibitor | [551393] | |
PANTHER Pathway | p38 MAPK pathway | ||||
CCKR signaling map ST | |||||
PathWhiz Pathway | Leucine Stimulation on Insulin Signaling | ||||
WikiPathways | Interferon type I signaling pathways | ||||
Hypertrophy Model | |||||
Insulin Signaling | |||||
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | |||||
ISG15 antiviral mechanism | |||||
Deadenylation-dependent mRNA decay | |||||
Structural Pathway of Interleukin 1 (IL-1) | |||||
BDNF signaling pathway | |||||
Leptin signaling pathway | |||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
Signaling by Insulin receptor | |||||
Processing of Capped Intron-Containing Pre-mRNA | |||||
Eukaryotic Translation Initiation | |||||
Translation Factors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.